Balyasny Asset Management L.P.

Position in PTCT — Ptc Therapeutics, Inc.

CIK 1218710 Chicago, IL

Position in PTCT

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$31,378,225

+$25,491,308 QoQ

Shares Held

460,564

+380.1% QoQ

Ownership

0.555%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Balyasny Asset Management L.P. holds $2,162,785,356 across 177 Biotechnology names. PTCT ranks #19 (1.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TERN	Terns Pharmaceuticals, Inc.	2,779,445	$146,532,340
2	ERAS	Erasca, Inc.	5,143,985	$83,229,677
3	TNGX	Tango Therapeutics, Inc.	3,826,659	$80,053,706
4	APLS	Apellis Pharmaceuticals, Inc.	1,917,501	$77,141,065
5	BMRN	Biomarin Pharmaceutical Inc	1,362,752	$76,981,860
6	CYTK	Cytokinetics Inc	992,545	$65,418,640
7	DAWN	Day One Biopharmaceuticals, Inc.	2,625,235	$56,285,038
8	FOLD	AMICUS THERAPEUTICS, INC.	3,827,513	$55,345,837

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$31,378,225	460,564	+380.1%	Shares	Sole	2026-05-15
2025-09-30	$5,886,917	95,925	+53.4%	Shares	Sole	2025-11-14
2024-09-30	$2,320,567	62,549	-31.6%	Shares	Sole	2024-11-14
2023-03-31	$4,429,159	91,436	-9.4%	Shares	Other	2023-05-15
2022-12-31	$3,852,574	100,932	-7.7%	Shares	Sole	2023-02-14
2022-03-31	$4,081,788	109,402	+31.1%	Shares	Sole	2022-05-16
2021-12-31	$3,322,698	83,422	-23.0%	Shares	Sole	2022-02-14
2021-09-30	$4,029,545	108,292	-55.8%	Shares	Sole	2021-12-01
2021-06-30	$10,349,048	244,832	+4360.4%	Shares	Sole	2021-08-16
2020-09-30	$256,610	5,489	-27.8%	Shares	Sole	2020-11-16
2020-06-30	$385,522	7,598	—	Shares	Sole	2020-08-14
No filing history on record for this holder in this stock.